XM tidak menyediakan perkhidmatan kepada penduduk Amerika Syarikat.

Southwest shareholders needn’t act like passengers



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>CORRECTED-BREAKINGVIEWS-Southwest shareholders needn’t act like passengers</title></head><body>

Corrects structure of Elliott’s ownership stake in paragraph 2. The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

By Jeffrey Goldfarb

NEW YORK, Aug 14 (Reuters Breakingviews) -Airplane passengers tolerate a lot of discomfort because of their limited choices. Shareholders often suffer similarly even though they’re not equally constrained. Southwest Airlines LUV.N, the discount carrier that Elliot Investment Management has turned into a battlefield, shows it doesn’t have to be that way.

The rabble-rousing hedge fund firm on Tuesday threatened to nominate 10 candidates, including the former chief executives of Air Canada AC.TO and Virgin America, to Southwest’s 15-person board. With an 8% beneficial ownership stake – 11% after adding other securities – in the $15 billion company, Elliott is close to having the requisite 10% to convene a special meeting of shareholders to advance its agenda, which ultimately involves ousting boss Robert Jordan. Southwest effectively dug in its heels, expressing confidence in its leadership and strategic plan.

Elliott’s timing is curious. It started its public campaign in June, shortly after shareholders enthusiastically elected Southwest’s proposed slate of board members, despite the airline’s shrinking operating profit margin and huge loss in market value. Such sheep-like behavior is all too common. Through mid-July, U.S. director nominees on average had received 95.3% of the ballot, 60 basis points higher than in 2023, according to consultancy Semler Brossy.

Look closer, however, and there are signs of frustration. More than a fifth of shareholders voted against Southwest’s executive pay plans, even though advisory firm Institutional Shareholder Services backed them. Moreover, eight out of 10 analysts rate the company either a “hold” or a “sell,” according to Visible Alpha, in a break with the typical deference to management that brokers provide.

Jordan has other reasons to worry too. Elliott hasn’t run a U.S. proxy battle since 2017, a sign that the many companies it targets are usually unnerved enough to make concessions. The CEOs of Starbucks SBUX.O, Johnson Controls International JCI.N and Crown Castle CCI.N also recently raised the white flag following the activist fund manager’s arrival on the scene.

On this occasion, shareholders may have to force the issue themselves if they want to shake things up. It’s a tall order. To oust a board member mid-term requires 50% support from all outstanding shares, as opposed to the mere plurality needed to win election at an annual meeting. Southwest is due to present its own plans for reviving its stock in September. Then shareholders can decide if they want to exert more influence than flyers typically do.

Follow @jgfarb on X


CONTEXT NEWS

Elliott Investment Management said on Aug. 13 that it plans to nominate 10 candidates for the board of Southwest Airlines in further pursuit of its aim to shake up the carrier.

Southwest responded on Aug. 14 that it had previously tried to engage with the activist investment firm, including arranging a meeting for early September. The company, which is being advised by Bank of America and Morgan Stanley, also said it is confident it has the right leadership team in place.

Elliott on June 10 disclosed an 11% stake in Southwest and urged changes to senior leadership as well as the board, currently made up of 15 directors.

The fund manager’s director candidates include former Ryanair Deputy CEO Michael Cawley, former Virgin America CEO David Cush and former Air Canada CEO Robert Milton.


Graphic: Southwest shareholders expressed only some displeasure https://reut.rs/4ctlkGv


Editing by John Foley and Sharon Lam

</body></html>

Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.

Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.

Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.

Amaran Risiko: Modal anda dalam risiko. Produk yang berleveraj mungkin tidak sesuai untuk semua individu. Sila pertimbangkan Pendedahan Risiko kami.